Press Release

visiongain

Chinese Pharmaceutical Market 2023

February 22nd, 2021 5:15 PM

Your guide to medical trends and drug revenues in China

What’s the outlook for the Chinese pharma market? Can it sustain high growth? Visiongain’s updated report gives you forecasted revenues there to 2023. That work also explains medical and technological trends, prospects and commercial opportunities.

Our study lets you assess sales data and detailed predictions. There, you investigate activities of domestic and international companies and assess their environment. That analysis shows you Chinese pharma’s most promising and lucrative areas.

China still holds great potential for medical sales. Read on to scan crucial features of that market, find what drives it, and see what its future could be worth to healthcare industries.

Forecasts and other analyses to help you stay ahead

Our report gives you revenue forecasts to 2023, historical data, growth rates and market shares. It lets you discover quantitative and qualitative analysis, business outlooks and developments (R&D). You also gain 77 tables, 76 charts and two research interviews.

Is finding medical and sales data on China proving difficult? With our study you can stay ahead in knowledge, benefiting your research, analyses and decisions. There you find trends, innovations and opportunities for human medicines. You see what’s happening.

Also, you discover future possibilities. Anyhow, the following sections show how you benefit from our new investigation and analysis.

Discover sales predictions for the Chinese market and its many submarkets

Along with revenue prediction for the overall Chinese pharma market, you see individual forecasts to 2023 for these main submarkets:
• Hospital sales
• Retail pharmacy sales
• Sales via other channels
• Conventional pharmaceuticals – with sub forecasts for novel and generic drugs
• Biological drugs – with sub forecasts for novel and biosimilar biologics, and for vaccines
• Traditional Chinese medicines (TCM).

Our study also gives you individual revenue forecasts to 2023 for pharma sales by therapeutic area:
• Infectious diseases
• Cancer
• Cardiovascular disorders
• Diabetes
• Respiratory diseases
• Autoimmune and inflammatory conditions
• Central nervous system (CNS) disorders
• Other medical needs (as a group).

You also see individual revenue forecasting to 2023 for these related industries in China:
• Contract medical sales
• Contract research – with sub forecasts for drug discovery outsourcing, and clinical trials outsourcing
• Contract manufacturing and other domestic pharmaceutical manufacturing – with division into drug formulations, active pharma ingredients (APIs), medical devices, TCM agents, and biologicals
• Medical devices – with sub forecasts for diagnostic imaging, consumables, orthopaedics and implanted medical devices, dental applications, and other devices.

Press Release

  • Recent
  • Popular
  • Comments
  • Cryotherapy Industry Growth Prospect, Future Trend, Comprehensive Analysis and Forecasts 2021 to 2026

    Learn More
  • Malaria Vaccines Industry 2021 In-depth Industry Analysis By Types, Applications

    Learn More
  • Scaffold Technology Industry 2026 : Detailed survey of the key competitors and the leading players

    Learn More
  • Healthcare IT Industry 2021 Global Industry Trends, Statistics, Competition Strategies, Revenue Analysis, Key Players

    Learn More
  • IBM Watson Services Market 2021-2028: Industry Analysis and Forecast

    Learn More
  • Lithium-Ion Battery Cathode Market Regional Analysis, Competitive Landscape and Forecast to 2028

    Learn More
  • Cell Banking Outsourcing Industry Opportunities Future Guidelines Value Chain Forecast To 2025

    Learn More
  • Visiongain Publishes Directed Energy Weapons (DEW) Market Report 2021-2031

    Learn More